HOUSTON and MILAN ― The University of Texas MD Anderson Cancer Center and Sibylla Biotech today announced a strategic collaboration agreement to discover and...

CAMERINO, ITALY and BOSTON, USA — June 12, 2024: Scientists at the School of Biosciences and Veterinary Medicine at the University...

City of Hope CAR T cell therapy for advanced prostate cancer demonstrates positive results in phase 1 clinical trial •  ...

Background Liver cancer is the sixth most common cancer and third leading cause of cancer death globally. According to Hong...

Early-stage cervical cancer patients see better survival and decreased recurrence rates after open radical hysterectomy than minimally invasive laparoscopic approaches,...

    · Weakened virus helps eliminate melanoma and colon cancer in mice · Therapy is effective in treating and...

Subscribe to UCSF News Subscribe to UCSF News Note to Editors: Speaker bios are available in our media kit   UCSF Health...

BOSTON—Metastatic cancer cells, which cause 90% of cancer-related deaths, must overcome numerous hurdles to spread from a primary tumor through...

Investigators from UCLA Health found using artificial intelligence to help map out the boundaries of cancerous prostate tissue can significantly...

In a new UCLA-led study, investigators shed light on the intricate processes underlying cancer evolution and define the optimal algorithms...